-
1
-
-
84898767802
-
Hepatocellular carcinoma: Clinical frontiers and perspectives
-
Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 2014;63:844-55.
-
(2014)
Gut
, vol.63
, pp. 844-855
-
-
Bruix, J.1
Gores, G.J.2
Mazzaferro, V.3
-
2
-
-
84868659263
-
Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria
-
Lim KC, Chow PK, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. Br J Surg 2012;99:1622-9.
-
(2012)
Br J Surg
, vol.99
, pp. 1622-1629
-
-
Lim, K.C.1
Chow, P.K.2
Allen, J.C.3
-
3
-
-
79953174883
-
Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: A 20-year experience
-
Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 2011;253:745-58.
-
(2011)
Ann Surg
, vol.253
, pp. 745-758
-
-
Fan, S.T.1
Mau Lo, C.2
Poon, R.T.3
-
4
-
-
79952231921
-
Management of hepatocellular carcinoma: An update
-
Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
-
(2011)
Hepatology
, vol.53
, pp. 1020-1022
-
-
Bruix, J.1
Sherman, M.2
-
5
-
-
84858658381
-
European organisation for research and treatment of cancer. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma
-
European Association For The Study Of The Liver1; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-43.
-
(2012)
J Hepatol
, vol.56
, pp. 908-943
-
-
European Association For The Study Of The Liver11
-
6
-
-
84857342543
-
Resection for hepatocellular carcinoma: Is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?
-
Chow PK. Resection for hepatocellular carcinoma: is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria? J Gastroenterol Hepatol 2012;27:452-7.
-
(2012)
J Gastroenterol Hepatol
, vol.27
, pp. 452-457
-
-
Chow, P.K.1
-
7
-
-
84901258639
-
Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma
-
Yau T, Tang VY, Yao TJ, et al. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 2014;146:1691-700.
-
(2014)
Gastroenterology
, vol.146
, pp. 1691-1700
-
-
Yau, T.1
Tang, V.Y.2
Yao, T.J.3
-
8
-
-
84905563720
-
Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma
-
Zhong JH, Ke Y, Gong WF, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 2014;260:329-40.
-
(2014)
Ann Surg
, vol.260
, pp. 329-340
-
-
Zhong, J.H.1
Ke, Y.2
Gong, W.F.3
-
9
-
-
20144388983
-
Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: Results of a multicenter study
-
Pawlik TM, Poon RT, Abdalla EK, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005;137:403-10.
-
(2005)
Surgery
, vol.137
, pp. 403-410
-
-
Pawlik, T.M.1
Poon, R.T.2
Abdalla, E.K.3
|